secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuwellis, Inc. (NUWE)
CIK:        0001506492
Form:       8-K
Filed at:   2024-08-13T23:59:59+00:00
Accession:  0001140361-24-036995
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nuwellis Q2 revenue up 6% to $2.2M; gross margin expands to 67.2%
-----------------------------------------------------------------

- Revenue $2.2M (+6% YoY); Critical Care revenue up 28%, Heart Failure consumables utilization up 35%.
- Gross margin 67.2% vs 55.3% prior year; total operating expenses down 38% to $3.8M.
- Net loss $7.7M vs $4.8M; basic EPS loss $18.85 vs $127.65 (improved due to share count changes).
- Cash and equivalents $1.0M; no debt; closed registered direct offering for $2.0M gross proceeds on July 25.
- Expanded Aquadex to pediatric patients in Florida hospital network; signed purchase agreement with 50-hospital Texas network.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506492/000114036124036995/0001140361-24-036995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506492/000114036124036995/ef20033985_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-036995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer